Save information for later
Sign Up

Learn About Juvenile Dermatomyositis

What is the definition of Juvenile Dermatomyositis?
Juvenile dermatomyositis has some similarities to adult dermatomyositis and polymyositis. Children with Juvenile dermatomyositis may have difficulty swallowing and breathing, and the heart may also be affected. About 20 to 30 percent of children with Juvenile dermatomyositis develop calcium deposits in the soft tissue. Affected children may not show higher than normal levels of the muscle enzyme creatine kinase in their blood but have higher than normal levels of other muscle enzymes.
What are the alternative names for Juvenile Dermatomyositis?
  • Juvenile dermatomyositis
  • Amyopathic dermatomyositis
  • Juvenile DM
  • ADM
  • Dermatomyositis sine myositis
Who are the top Juvenile Dermatomyositis Local Doctors?
4940 Eastern Ave, 
Baltimore, MD 
 31.0 mi
Recognized by The Myositis Association

Andrew Mammen is a Neurologist in Baltimore, Maryland. Dr. Mammen and is rated as an Elite provider by MediFind in the treatment of Juvenile Dermatomyositis. His top areas of expertise are Myositis, Dermatomyositis, Polymyositis, and Necrotizing Myopathy (NM).

Lisa G. Rider
Pediatric Rheumatology
Pediatric Rheumatology

NIH Clinical Center

10 Center Dr, NIHBC 10 - CRC - HATFIELD, 
Bethesda, MD 
 40.0 mi
Recognized by The Myositis Association

Lisa Rider is a Pediatric Rheumatologist in Bethesda, MD. Dr. Rider and is rated as an Elite provider by MediFind in the treatment of Juvenile Dermatomyositis. Her top areas of expertise are Juvenile Dermatomyositis, Dermatomyositis, Arthritis, and Pulmonary Alveolar Proteinosis.

 
 
 
 
Learn about our expert tiers
Learn More

Medical Faculty Associates, Inc

2300 M St Nw, 
Washington, DC 
 46.4 mi
Offers Telehealth

Rodolfo Curiel is a Rheumatologist in Washington, Washington, D.c.. Dr. Curiel has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Juvenile Dermatomyositis. His top areas of expertise are Juvenile Dermatomyositis, Dermatomyositis, Polymyositis, and Myositis.

What are the latest Juvenile Dermatomyositis Clinical Trials?
Studies of Natural History, Pathogenesis, and Outcomes in Autoimmune and Inflammatory Diseases Including Juvenile Dermatomyositis

Eligibility: * Patients with known NOMID/CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, and with other yet undifferentiated autoinflammatory diseases. * Healthy adult and pediatric relatives. * Volunteers

Match to trials
Find the right clinical trials for you in under a minute
Get started
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)

Summary: This study is an open-label, single-arm, dose-escalation trial primarily designed to evaluate the safety and efficacy of a universal CAR-T cell therapy targeting CD19 in the treatment of patients with RJDM. Additionally, the study aims to characterize its pharmacokinetic and pharmacodynamic properties, explore its role in immune system reconstitution, and assess long-term survival benefits.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center